Laxans

Bisacodyl, the active ingredient in Laxans, is a stimulant laxative presented as an oral dosage form for oral use. It is employed to relieve occasional constipation and to assist bowel cleansing before diagnostic procedures in adults. It is available over the counter in many European markets and is formulated for rapid onset of action.

GNH USA supplies Laxans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable supply chains across multiple regions.

Bisacodyl is a stimulant laxative that works on the colon to treat constipation and related conditions.

Constipation: provides relief of occasional constipation by stimulating bowel movements. Bowel preparation: used as part of a bowel cleansing regimen before colonoscopy or other diagnostic procedures. Opioid‑induced constipation: helps alleviate reduced gastrointestinal motility caused by opioid therapy.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps - Diarrhea - Nausea - Rectal irritation - Thirst - Loose stools

Serious or Rare Side Effects: - Severe electrolyte imbalance - Dehydration - Allergic reaction (rash, itching, swelling) - Colitis - Rectal bleeding - Severe abdominal pain

When using Bisacodyl, certain precautions should be observed to ensure safe and effective therapy.

Assess hydration status: ensure adequate fluid intake before and during treatment. Use lowest effective dose: limit duration to avoid dependence. Avoid prolonged use: not recommended for chronic constipation without medical supervision. Contraindicated in intestinal obstruction: do not use if bowel blockage is present. Caution in elderly patients: monitor for electrolyte disturbances. Store at room temperature: keep in original packaging, protect from moisture and heat.

Bisacodyl can interact with other medicines, altering its efficacy or increasing risk of adverse effects.

Major Interactions (Avoid): - Anticholinergic agents: may reduce laxative effect. - Loop diuretics: increase risk of electrolyte imbalance. - Cardiac glycosides: heightened risk of arrhythmia due to potassium loss.

Moderate Interactions (Monitor Closely): - NSAIDs: additive gastrointestinal irritation. - Potassium supplements: may counteract electrolyte loss. - Antidepressants (SSRIs): monitor for rare serotonin syndrome when combined with other serotonergic agents.